Patents
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
04/2004
04/29/2004WO2003086282A3 Nitric oxide donors, compositions and methods of use
04/29/2004US20040082805 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents
04/29/2004US20040082592 Metabotropic glutamate receptor antagonists
04/29/2004US20040082561 Antilipemic agents; anticholesterol agents
04/29/2004US20040082542 Useful as modulators of interaction between receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, beta-amyloid and amphoterin
04/29/2004CA2500635A1 Process for the preparation of (s,s)-cis-2-benzhydryl-3-benzylaminoquinuclidine
04/28/2004EP1411946A1 Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses
04/28/2004EP1411945A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists
04/28/2004EP1411940A1 Bridged piperidine derivatives as melanocortin receptor agonists
04/28/2004CN1492868A Quinuclidine carbamate derivatives and their use as m3 antigonists
04/28/2004CN1147483C Adamantane derivatives
04/27/2004US6727247 Adenosine receptor ligands in a method of treatment, control, or prevention of central nervous system disorders
04/22/2004US20040077707 Pyrrole based inhibitors of glycogen synthase kinase 3
04/22/2004US20040077648 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis
04/21/2004CN1146565C Polymorphs of crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
04/15/2004WO2003103567A3 Nitrosodiphenylamine derivatives, compositions comprising them, and the use thereof as antioxidants and spontaneous nitric oxide donors
04/15/2004US20040072863 Novel quinuclidine derivatives and medicinal compositions containing the same
04/15/2004US20040072830 Squalene synthetase inhibitors; antilipemic agents; antiischemic agents; cardiovascular disorders; anticholesterol agents
04/14/2004EP1406900A1 Novel compounds, their preparation and use
04/14/2004EP1375465A9 Cyclooctanone derivative and cyclodecanone derivative, and use thereof
04/14/2004EP1305270B1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
04/08/2004WO2004029050A1 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
04/08/2004US20040067966 Adenosine receptor antagonists and methods of making and using the same
04/08/2004US20040067930 Central nervous system disorders; neurotransmitters; side effect reduction
04/08/2004US20040067911 Antidiabetic agents; hypoglycemic agents
04/07/2004EP1405638A1 Medicinal composition for treatment of interstitial cystitis
04/07/2004EP1404674A2 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors
04/07/2004CN1487938A Quinuclidine derivatives and their use as M3 antagonists
04/06/2004CA2124306C Quinazolinone derivatives
04/01/2004WO2004026844A1 Methods and compositions of novel triazine compounds
04/01/2004US20040063950 Carbamates derivatived from arylakylamines
04/01/2004CA2499964A1 Methods and compositions of novel triazine compounds
03/2004
03/31/2004EP1282620B1 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
03/25/2004WO2003090680A3 Novel phenyl derivatives as inducers of apoptosis
03/18/2004WO2004022556A1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist
03/18/2004WO2003094830A3 Novel azacyclic ethynyl derivatives
03/18/2004WO2003070731A3 Azabicyclic compounds for the treatment of disease
03/18/2004US20040054187 Therapeutic ureas
03/18/2004US20040054173 Antiinflammatory agents; autoimmune disease; antiarthritic agents
03/17/2004CN1483028A Quinolinone derivatives as tyrosine kinase inhibitors
03/11/2004US20040049032 Inhibitors of protein kinases, especially Aurora kinase; anticancer agents
03/10/2004EP1396489A1 Heteroaromatic bicyclic derivatives useful as anticancer agents
03/10/2004EP1396488A1 Fused heterocyclic compound and medicinal use thereof
03/10/2004EP1395265A2 Combretastatin a-3 prodrug
03/10/2004EP0994875B1 3-pyridyl-1-azabicycloalkane derivatives for prevention and treatment of cns disorders
03/04/2004WO2004018458A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
03/04/2004WO2004018455A1 Pyrrole based inhibitors of glycogen synthase kinase 3
03/04/2004WO2004018420A1 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists
03/04/2004WO2004018419A2 Benzimidazole quinolinones and uses thereof
03/04/2004WO2003082350A3 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
03/04/2004US20040044044 Thiazolyl urea compounds and methods of uses
03/04/2004US20040044026 3-Substituted quinuclidines and their use as nicotinic agonists
03/04/2004DE10305922A1 New N-azabicyclooctyl bicyclic heteroaryl carboxamides, are alpha 7-nicotinic acetylcholine receptor ligands useful for improving attention, concentration, learning and/or memory performance
03/04/2004DE10238045A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical
03/04/2004CA2501849A1 2-thio-substituted imidazole derivatives and their use in treating diseases associated with a disorder of the immune system
03/04/2004CA2496246A1 Pyrrole based inhibitors of glycogen synthase kinase 3
03/03/2004CN1140516C Quinoline and quinoxaline compounds which inhibits platelet-derived growth factor on/or p56lck tyrosine kinases
02/2004
02/26/2004WO2004016608A1 Novel quinuclidine derivatives and their use
02/26/2004WO2004016590A1 The salts of the quinuclidine derivatives and the preparation and applications thereof
02/26/2004US20040039029 Thiazolyl urea compounds and methods of uses
02/26/2004US20040038957 Anti-malarial activity
02/26/2004CA2493245A1 Novel quinuclidine derivatives and their use
02/25/2004EP1300407B1 Carbamates derived from arylalkylamines
02/25/2004EP0906297B1 1,2,4-benzothiadiazine derivatives, their preparation and use
02/24/2004US6696434 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
02/19/2004WO2004000840A3 Quinuclidine derivatives and pharmaceutical compositions containing the same
02/19/2004US20040034246 Radiofluorinated imaging agents which are utilzed in Positron Emission Tomography for diagonsis of Parkinson's disease
02/19/2004US20040034078 Such as 2-(2-butylamino-ethylsulfanylmethyl)-1H-benzimidazole-4-carboxylic acid amide for treatment of cancer, strokes, head trauma, and neurodengenerative diseases; solid phase synthesis
02/19/2004US20040034019 Piperazine and piperidine derivatives
02/18/2004EP1389208A1 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor antagonists)
02/18/2004EP0912563B1 Cinchonan based chiral selectors for separation of stereoisomers
02/17/2004CA2290918C Heteroaromatic bicyclic derivatives useful as anticancer agents
02/12/2004WO2004013137A1 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity
02/12/2004WO2004013136A1 Benzothiophene urea, benzofurane urea, and indole urea, and use of the same as alpha-7 achr agonists
02/12/2004WO2004012671A2 Substituted furo [2,3-b] pyridine derivatives
02/12/2004US20040029919 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence
02/12/2004US20040029912 Bicyclic derivatives
02/12/2004US20040029838 Anticancer agents
02/12/2004DE10234424A1 Benzothiophen-, Benzofuran- und Indolharnstoffe Benzothiophene, benzofuran and Indolharnstoffe
02/10/2004CA2291975C Quaternary ammonium compounds
02/05/2004US20040024059 Novel pleuromutilin derivatives
02/05/2004US20040023290 Novel therapeutic agents that modulate enzymatic processes
02/04/2004EP1385846A2 Synthesis of pancratistatin prodrugs
02/04/2004EP0608307B1 New ligands for asymmetric dihydroxylation: multiple cinchona alkaloid units attached to a central heterocyclic core
01/2004
01/28/2004EP1383730A2 Anticholinergic compounds and methods of use
01/28/2004CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them
01/27/2004US6683090 N-(1-azabicyclo(2.2.2)oct-3-yl)propenamide derivatives; psychotic and intellectual impairment disorders
01/22/2004WO2004006930A1 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
01/21/2004EP1381603A2 Quinuclidine-substituedaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands )
01/15/2004WO2004005293A2 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
01/15/2004WO2004005285A1 New quinuclidine amide derivatives
01/15/2004CA2492535A1 New quinuclidine amide derivatives
01/14/2004EP1379510A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers
01/08/2004WO2004002964A1 Diaminopyrimidinecarboxa mide derivative
01/08/2004US20040006101 Quinolinone derivatives
01/08/2004US20040006084 For therapy and prophylaxis of inflammatory diseases, asthma
01/08/2004DE10227506A1 Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Ring-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use
01/07/2004EP1175417B1 Substituted benzolactam compounds
01/02/2004EP1375500A1 Isoquinuclidine derivative, process for producing the same, and medicinal composition containing the same
01/02/2004EP1375496A1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 58